Pathogenesis of immunogenic hyperthyroidism and endocrine orbitopathy;Pathogenese der immunogenen hyperthyreose und endokrinen orbitopathie

Internist

Volumn 39, Issue 6, 1998, Pages 599-606

  Heufelder, A E ^a   Spitzweg, Ch ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL ADHESION MOLECULE; CYTOKINE; HLA DR ANTIGEN; THYROTROPIN RECEPTOR;

ALTERNATIVE RNA SPLICING; EYE DISEASE; GENETIC POLYMORPHISM; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNOCYTOCHEMISTRY; IODINE DEFICIENCY; PATHOGENESIS; REVIEW; T LYMPHOCYTE;

AUTOANTIBODIES; AUTOANTIGENS; CELL ADHESION MOLECULES; CYTOKINES; GRAVES DISEASE; HUMANS; ORBIT; RECEPTORS, THYROTROPIN; T-LYMPHOCYTES;

EID: 0031806481     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050219     Document Type: Review

References (70)

1. Arscott P, Rosen ED, Koenig RJ, Kaplan MM, Ellis T, Thompson N, Baker JR (1992) Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 75: 295-300
2. Badenhoop K, Donner H, Braun J, Siegmund T, Rau H, Usadel KH (1997) Genetic markers in diagnosis and prediction of relapse in Graves' disease. Exp Clin Endocrinol Diabetes 104 [Suppl 4]:98-100
3. Bahn RS, Dutton CM, Heufelder AE, Sarkar G (1994) A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 78:256-260
4. Bahn RS, Gorman CA, Johnson CM, Smith TJ (1989) Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kDa fibroblast protein. J Clin Endocrinol Metab 69:622-628
5. Bahn RS, Heufelder AE (1993) Mechanisms of disease: Pathogenesis of Graves'ophthalmopathy. N Engl J Med 329:1468-1475
6. Burch HB, Wartofsky L (1993) Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 14:747-793
7. Burman KD, Baker JR (1985) Immune mechanisms in Graves'disease. Endocr Rev 6:183-232
8. Couet J, Sar S, Jolivet A, Hai MTV, Milgrom E, Misrahi M (1996) Shedding of human thyrotropin receptor ectodomain. J Biol Chem 271:4545-4552
9. Crisp MS, Lane C, Halliwell M, Wynford TD, Ludgate M (1997) Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab 82:2003-2005
10. Cuddihy RM, Dutton CM, Bahn RS (1994) A genomic TSH receptor point mutation is highly associated with autoimmune thyroid disease in females. Thyroid 4: S-26
11. Cuddihy RM, Dutton CM, Spicer AP, McDonald JA, Bahn RS (1997) Human hyaluronan synthetase gene expression in retroorbital fibroblasts from patients with Graves'ophthalmopathy. Thyroid 7 [Suppl 1]: S1-11
12. Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A (1991) Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med 325:238-244
13. DeGroot LJ, Quintans J (1989) The causes of autoimmune thyroid disease. Endocr Rev 10:537-562
14. Dutton CM, Joba W, Spitzweg C, Heufelder AE, Bahn RS (1997) Thyrotropin receptor is expressed in Graves'orbital connective tissue specimens, but is lost in late-passage orbital fibroblasts. Thyroid 7 [Suppl 1]: S1-105
15. Dutton CM, Joba W, Spitzweg C, Heufelder AE, Bahn RS (1997) Thyrotropin receptor expression in adrenal, kidney and thymus. Thyroid 7:879-884
16. Endo T, Ohmori M, Ikeda M, Anzai E, Onaya T (1992) Heterogenous responses of recombinant human thyrotropin receptor to immunoglobulins from patients with Graves' disease. Biochem Biophys Res Commun 186:1391-1396
17. Faure GC, Bensoussan-Lejzerowicz D, Bene MC, Aubert V, Ledere J (1997) Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells. Clin Immunol Immunopathol 84:212-215
18. + and specifically recognize autologous fibroblasts. J Clin Invest 93:2738-2743
19. Heldin N-E, Gustavsson B, Westermark K, Westermark B (1991) A somatic point mutation in a putative ligand binding domain of the TSH receptor in a patient with autoimmune hyperthyroidism. J Clin Endocrinol Metab 73:1374-1376
20. Heuer M, Aust G, Ode-Hakim S, Scherbaum WA (1997) Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 6:97-106
21. Heufelder AE (1995) Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy. Thyroid 5:331-340
22. Heufelder AE (1997) Retro-orbital autoimmunity. Baillière's Clinical Endocrinology and Metabolism 11:499-520
23. Heufelder AE, Bahn RS (1992) Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves'ophthalmopathy. Exp Clin Endocrino 100:62-67
24. Heufelder AE, Bahn RS (1992) Modulation of intercellular adhesion molecule-1 (ICAM-1) by cytokines and Graves' IgGs in cultured Graves' retroocular fibroblasts. Eur J Clin Invest 22:529-537
25. Heufelder AE, Bahn RS (1993) Detection and localization of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 23:10-17
26. Heufelder AE, Bahn RS (1993) Elevated expression in situ of selectin and immunoglobulin superfamily adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy. Clin Exp Immunol 91:381-389
27. Heufelder AE, Bahn RS (1993) Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases. Clin Exp Immunol 92:296-302
28. Heufelder AE, Bahn RS, Scriba PC (1995) Analysis of T-cell antigen receptor variable region gene usage in patients with thyroid-related pretibial dermopathy. J Invest Dermatol 105:372-378
29. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS (1993) Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 3:297-300
30. Heufelder AE, Herterich S, Ernst G, Bahn RS, Scriba PC (1995) Analysis of retroorbital T cell antigen receptor variable region gene usage in patients with Graves' ophthalmopathy. Eur J Endocrinol 132:266-277
31. Heufelder AE, Scriba PC (1996) Characterization of adhesion receptors on cultured microvascular endothelial cells derived from the retroorbital connective tissue of patients with Graves' ophthalmopathy. Eur J Endocrinol 134:51-60
32. Heufelder AE, Wenzel BE, Scriba PC (1996) Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease. J Clin Endocrinol Metab 81:3733-3739
33. Hörmann R, Spitzweg C, Poertl S, Mann K, Heufelder AE, Schumm-Draeger PM (1997) Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: Role of Graves'immunoglobulins and human TSH receptor. J Clin Endocrinol Metab 82:2048-2055
34. Hofbauer LC, Mühlberg T, König A, Heufelder G, Schworm H-D, Heufelder AE (1997) Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab 82:2244-2247
35. Hunt N, Willey KP, Abend N, Balvers M, Jähner D, Northemann W, Ivell R (1995) Novel splicing variants of the human thyrotropin receptor encode truncated polypeptides without a membrane-spanning domain. Endocrine 3:233-240
36. Jankovic SM, Radosavlievic VR, Marinkovic JM (1997) Risk factors for Graves' disease. Eur J Epidemiol 13:19-23
37. Kaback LA, Smith TJ (1997) Expression and regulation of hyaluronan synthase (HS) mRNAs in primary human fibroblasts: potential insights into diseases of the thyroid. Thyroid 7 [Suppl 1]:S1-10
38. Kadlubowski M, Irvine MJ, Rowland AC (1986) The lack of specifity of ophthalmic immunglobulins in Graves' disease. J Clin Endocrinol Metab 63:990-995
39. Kallmann BA, Hüther M, Tubes M, Feldkamp J, Bertrams J, Gries FA, Lampeter EF, Kolb H (1997) Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves'disease. Diabetes 46:237-243
40. Kendler DL, Rootman J, Huber GK, Davies TF (1991) A 64 kDa membrane antigen is a recurrent epitope for natural antibodies in patients with Graves'thyroid and ophthalmic abnormalities. Clin Endocrinol 35:539-547
41. Kosugi S, Ban T, Akamizu T, Kohn LD (1992) Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Mol Endocrinol 6:168-180
42. Kosugi S, Ban T, Kohn L (1993) Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. Mol Endocrinol 7:114-130
43. Kotsa K, Watson PF, Weetman AP (1997) A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endorinol 46:551-554
44. Lee JH, An MA, Jeon JS, Song CU, Shong M, Kim YK, Ro HK (1997) Circulating intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease and Hashimoto disease. J Intern Med 10:10-15
45. Loos U, Hagner S, Bohr URM, Bogatkewitsch GS, Jakobs KH, van Koppen CJ (1995) Enhanced cAMP accumulation by the human thyrotropin receptor variant with the Pro52Thr substitution in the extracellular domain. Eur J Biochem 232:62-65
46. 1-integrin expression in autoimmune thyroid disorders. Clin Exp Immunol 109:107-115
47. Molnar I, Balazs C (1997) High circulating IL-6 level in Graves' ophthalmopathy. Autoimmunity 25:91-96
48. Murakami M, Hosoi Y, Negishi T et al. (1996) Thymic hyperplasia in patients with Graves' disease. J Clin Invest 98:2228-2234
49. Nagayama Y, Takeshita A, Luo W, Ashizawa K, Yokoyama N, Nagataki S (1994) High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain. Thyroid 4:155-159
50. Pappa A, Calder V, Ajjan R, Fells P, Ludgate M, Weetman, Lightman S (1997) Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol 109:362-369
51. Pappa A, Calder V, Fells P, Lightman S (1997) Adhesion molecule expression in vivo on extraocular muscle (EOM) in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol 108:309-313
52. Paschke R, Metcalfe A, Alcalde L, Vassart G, Weetman A, Ludgte M (1994) Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues. J Clin Endocrinol Metab 79:1234-1238
53. Philippou G, de Roux N, Ratanachatyavong S, Campbell RD, McGregor AM (1997) Graves' disease: heterogeneity within a multifactorial polygenic disease? What is the phenotype? Thyroid 7:680
54. Prummel MF, Wiersinga WM (1993) Smoking and risk of Graves'disease. J Am Med Assoc 269:479-482
55. Ross PV, Koenig RJ, Arscott P et al. (1993) Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease. J Clin Endocrinol Metab 77:433-438
56. Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T (1997) Increased expression of the Na+/I-symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocrinol Metab 82:3331-3336
57. Salvi M, Miller A, Wall JR (1988) Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 232:135-139
58. Salvi M, Zhang Z-G, Haegert D et al. (1990) Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab 70:89-94
59. Soliman M, Kaplan E, Yanagawa T, Hidaka Y, Fisfalen M-E, DeGroot LJ (1995) T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain. J Clin Endocrinol Metab 80:905-914
60. Spitzweg C, Joba W, Heufelder AE (1997) Analysis of human sodium iodide symporter gene expression in patients with thyroid diseases. 79th Annual Meeting of The Endocrine Society (Minneapolis/USA) 108:OR 30-1
61. Spitzweg C, Joba W, Hunt N, Heufelder AE (1997) Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue. Eur J Endocrinol 136:599-607
62. Stadlmayr W, Spitzweg C, Bichlmair A-M, Heufelder AE (1997) TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Thyroid 7:3-12
63. Takeshita A, Nagayama Y, Fujiyama K et al. (1992) Molecular cloning and sequencing of an alternatively spliced form of the human thyrotropin receptor transcript. Biochem Biophys Res Commun 188:1214-1219
64. Tamura K, Woo J, Murase N, Carrieri G, Nalesnik MA, Thomson AW (1993) Suppression of autoimmune thyroid disease by FK 506; influence on thyroid-infiltrating cells, adhesion molecule expression and antithyroglobulin antibody production. Clin Exp Immunol 91:368-375
65. Tomer Y, Davies TF (1993) Infection, thyroid disease, and autoimmunity. Endocr Rev 14:107-120
66. Watson PF, Pickerill AP, Davies R, Weetman AP (1994) Analysis of cytokine gene expression in Graves'disease and multinodular goiter. J Clin Endocrinol Metab 79:355-360
67. Weetman AP, Cohen S, Gatter KC, Fells D, Shine B (1989) Immunohistochemical analysis of the retrobulbar tissues in Graves' opthalmopathy. Clin Exp Immunol 75:222-227
68. Weetman AP, Fells P, Shine B (1989) T and B cell reactivity to extraocular and skeletal muscle in Graves'ophthalmopathy. Br J Ophthalmol 73:323-327
69. Wenzel BE, Heesemann J, Wenzel KW, Scriba PC (1988) Antibodies to plasmid-encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1:56
70. Winsa B, Adami H-O, Bergström R, Gamstedt A, Dahlberg PA, Adamson U, Jansson R, Karlsson A (1991) Stressful life events and Graves' disease.Lancet 338:1475-1479